Endogenous atrial natriuretic peptide inhibits endothelin-1 secretion in dogs with severe congestive heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 5 39-5, 1996, Pages

  Wada, Atsuyuki ^a   Tsutamoto, Takayoshi ^b   Maeda, Yukiharu ^b   Kanamori, Toshiyuki ^b   Matsuda, Yuzuru ^b   Kinoshita, Masahiko ^b  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b NONE

Author keywords

angiotensin II; arginine vasopressin; guanosine 3',5' cyclic monophosphate

Indexed keywords

ANGIOTENSIN; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; ENDOTHELIN 1;

ANIMAL MODEL; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; HORMONE RELEASE; LUNG ARTERY PRESSURE; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0029889793     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.5.h1819     Document Type: Article

References (34)

1. Boulanger, C., and T. F. Lüscher. Release of endothelin from the porcine aorta. J. Clin. Invest. 85: 587-590, 1990.
2. Cavero, P. G., W. L. Miller, D. M. Heublein, K. B. Margulies, and J. C. Burnett, Jr. Endothelin in experimental congestive heart failure in the anesthetized dog. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physiol. 28): F312-F317, 1990.
3. Cody, R., S. Atlas, J. Laragh, S. Kubo, A. Covit, K. Ryman, A. Shaknovich, K. Pondolfino, M. Clark, M. Camargo, M. Scarborough, and J. Lewicki. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J. Clin. Invest. 78: 1362-1374, 1986.
4. Cody, R. J., G. J. Haas, P. F. Binkley, Q. Capers, and R. Kelley. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85: 504-509, 1992.
5. Emori, T., Y. Hirata, K. Ohta, M. Shichiri, and F. Marumo. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem. Biophys. Res. Commun. 160: 93-100, 1989.
6. Goetz, K. L., B. C. Wang, J. B. Madwed, J. L. Zhu, and J. R. J. Leadley. Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am. J. Physiol. 255 (Regulatory Integrative Camp. Physiol. 24): R1064-R1068, 1988.
7. Haung, C., H. Ives, and M. Cogan. In vivo evidence that cGMP is the second messenger for atrial natriuretic factor. Proc. Natl. Acad. Sci. USA 83: 805-8018, 1986.
8. Hirata, Y., H. Matsuoka, E. Suzuki, H. Hayakawa, T. Sugimoto, Y. Matsuda, Y. Morishita, K. Kangawa, N. Minamino, H. Matsuo, and T. Sugimoto. Role of endogenous atrial peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Circulation 87: 554-561, 1993.
9. Hu, R. M., E. R. Levin, A. Pedram, and H. J. L. Frank. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. J. Biol. Chem. 267: 17384-17389, 1992.
10. Imura, R., T. Sano, J. Goto, K. Yamada, and T. Matsuda. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptor. Mol. Pharmacol. 42: 982-990, 1992.
11. Kohno, M., T. Horio, K. Yokokawa, T. Fikui, K. Tasunari, K. Murakawa, N. Kurihara, and T. Takeda. Natriuretic peptides inhibit mesangial cell production of endothelin induced by arginine vasopressin. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F678-F683, 1993.
12. Kohno, M., E. Yasunari, K. Yokokawa, K. Murakawa, T. Horio, and T. Takeda. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J. Clin. Invest. 87: 1999-2004, 1991.
13. Kohno, M., K. Yokokawa, T. Horio, K. Yasunari, K. Murakawa, and T. Takeda. Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta. Circ. Res. 70: 241-247, 1992.
14. Lüscher, T. F. Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease. Eur. Heart J. 10: 847-857, 1989.
15. Margulies, K. B., F. L. Hildebrand, Jr., A. Lerman, M. A. Perrella, and J. C. Burnett, Jr. Increased endothelin in experimental heart failure. Circulation 82: 2226-2230, 1990.
16. Miller, W. L., M. M. Redfield, and J. C. Burnett, Jr. Integrated cardiac, renal, and endocrine actions of endothelin. J. Clin. Invest. 83: 317-320, 1989.
17. Milner, P., P. Bodin, A. Loeseh, and G. Burnstock. Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem. Biophys. Res. Commun. 170: 649-656, 1990.
18. Moe, G. W., R. Canepa-Anson, and P. W. Armstrong. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure. J. Cardiovasc. Pharmacol. 19: 691-700, 1992
19. Morishita, Y., T. Sano, K. Ando, Y. Saitoh, H. Kase, K. Yamada, and Y. Matsuda. Microbial polysaceharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem. Biophys. Res. Commun. 176: 949-957, 1991.
20. Nachshon, S., O. Zamir, Y. Matsuda, and N. Zamir. Effects of ANP receptor antagonists on ANP secretion from adult rat cultured atrial myocytes. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E428-E432, 1995.
21. 2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J. Biol. Chem. 269: 11938-11944, 1994.
22. Rathinavelu, A., and G. E. Isom. Differential internalization and processing of atrial-natriuretic-factor B and C receptors in PC12 cells. Biochem. J. 276: 493-497, 1991.
23. Resink, T., A. Hahn, T. Scott-Burden, J. Powell, E. Weber, and F. Bühler. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 168: 1303-1310, 1990
24. Saijonmaa, O., A. Ristimäki, and F. Fyhrquist. Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem. Biophys. Res. Commun. 173: 514-520, 1990.
25. Sano, T., R. Imura, Y. Morishita, Y. Matsuda, and K. Yamada. HS-142-1, a novel polysaccharide of microbial origin, specifically recognizes guanylyl cyclase-linked ANP receptor in rat glomeruli. Life Sci. 51: 1445-1451, 1992.
26. Sano, T., Y. Morishita, Y. Matsuda, and K. Yamada. Pharmacological profile of HS-142-1, a novel nonpeptide atrial peptide antagonist of microbial origin. I. selective inhibition of the actions of natriuretic peptides in anesthetized rats. J. Pharmacol. Exp. Ther. 260: 825-831, 1992.
27. Shimokawa, H., and P. M. Vanhoutte. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemic and atherosclerosis. Circ. Res. 64: 900-914, 1989.
28. Tsutamoto, T., K. Bito, and M. Kinoshita. Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure. Am. Heart J. 117: 599-606, 1989.
29. Tsutamoto, T., T. Kanamori, A. Wada, and M. Kinoshita. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. J. Am. Coll. Cardiol. 20: 541-546, 1992.
30. Tsutamoto, T., A. Wada, Y. Maeda, T. Adachi, and M. Kinoshita. Relationship between endothelin-1 spillover in the lungs and the pulmonary vascular resistance in patients with chronic heart failure. J. Am. Coll. Cardiol. 23: 1427-1433, 1994.
31. Underwood, R. D., L. L. Aarhus, D. M. Heufolein, and J. C. Burnett, Jr. Endothelin in thoracic inferior vena caval constriction model of heart failure. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H951-H955, 1992.
32. Wada, A., T. Tsutamoto, Y. Matsuda, and M. Kinoshita. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptides in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase coupled receptor. Circulation 89: 2232-2240, 1994.
33. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature Land. 332: 411-415, 1988.
34. Yoshizumi, M., H. Kurihara, T. Sugiyama, F. Takaku, M. Yanagisawa, T. Masaki, and Y. Yazaki. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem. Biophys. Res. Commun. 161: 859-864, 1989.